Pharmaceutical Executive October 8, 2025
Nicholas Jacobus, Shauna Tetrald, PhD

Shauna Tetrald, PhD, Director of Product Marketing at Quanterix, discussed translating complex scientific findings into actionable insights for healthcare providers and stakeholders, emphasizing the importance of early disease detection.

PE: The recent JAMA study highlights the association between biomarkers like p-tau181, NfL, and GFAP and early cognitive decline. From a product marketing perspective, how do you approach translating complex scientific findings like these into actionable insights for healthcare providers and stakeholders?
Tetrault: Yes, I think it’s important when a study like the JAMA study on subjective cognitive decline comes out to be able to translate it in such a way that it makes sense for a general audience as well as clinicians, right? And the significance of this study was interesting...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Interview / Q&A, Provider, Trends
Infographic: 3 Social Media Tips for CNOs
What Home-Based Care Consumers Really Want
283: A candid conversation: Physicians on the front lines of GLP‑1 care
The 250 best hospitals, according to Healthgrades
STAT+: 9 influencers shaping health information online, for better or worse

Share Article